MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced that its Compensation Committee recently approved inducement grants of restricted stock units (RSUs) covering 7,200 shares of common stock. These grants, dated February 19, 2025, were awarded to thirteen newly hired employees as part of the company’s efforts to attract top talent to its team.
The RSUs, granted under Nasdaq Rule 5635(c)(4), serve as an inducement material for the individuals’ acceptance of their roles at TELA Bio. This move reflects the company’s commitment to providing competitive and compelling compensation packages aimed at supporting its growth and innovation in the healthcare sector.
Under the terms of the grants, the RSUs will vest in equal annual installments over a four-year period. Vesting is contingent upon the recipients’ continued service with TELA Bio, ensuring long-term alignment with the company’s goals and stability within its workforce.
These inducement grants highlight TELA Bio’s ongoing investment in its employees as a critical component of its strategic vision. By using equity-based incentives, the company underscores its dedication to building a motivated and engaged team capable of driving its mission forward.
Looking ahead, these grants are expected to strengthen TELA Bio’s ability to attract and retain top talent, bolstering its workforce as it continues to expand its footprint in the medical industry.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.